IPAS158
Concessão de registro
RPI 2525
05/28/2019
Back to search
Official data from INPI
CAMBER FARMACÊUTICA LTDA
Did you know this trademark is already registered in Brazil?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Registro de marca em vigorType: CombinedOffice: Brazil
Progress at the INPI
- Filing08/09/18
- Publication08/28/18
- Examination
- Allowance04/30/19
- Grant05/28/19
- In force05/28/29
The registration was granted on 05/28/2019 and is in force until 05/28/2029, when it must be renewed.
Protection valid until:05/28/2029
Latest action published by the INPI: 05/28/2019. We update with every new RPI gazette, published weekly.
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
INPI status
Registro de marca em vigor
Case type
Application and registration
Recorded events
3
Latest update
05/28/2019
Trademark type
Combined
Nice classes
39
Filing date
08/09/2018
Registration date
05/28/2019
Expiration date
05/28/2029
Complete case details
Structured fields from the responsible authority and the official record.
Nature
De Serviço
Responsible office
Brazil
Owner type
PESSOA JURÍDICA
Owner location
SP, BR
Holders and representatives
Holders
CAMBER FARMACEUTICA LTDA
Representatives
Vaz e Dias Advogados & Associados
13333343000110
Technical classification
Nice Classes
Class 39
Vienna Codes
26.11.12
Goods and services
Class 39
Distribuição, transporte e armazenamento de produtos químicos, farmacêuticos, medicamentos, suplementos alimentares e produtos similares ou relacionados
Publications
History of INPI decisions and trademark events.
3 publications found
IPAS029
Deferimento do pedido
RPI 2521
04/30/2019
IPAS009
Publicação de pedido de registro para oposição (exame formal concluído)
RPI 2486
08/28/2018
Related trademarks
Continuous trademark protection
Get notified about every new filing that threatens CAMBER FARMACÊUTICA LTDA or your mark.
Professional 24-month watch service: we monitor INPI for you and alert you in time to oppose — before conflicts become losses.